To further confirm that the protection of RSG against HT and BBB disruption in tPA‐treated stroke mice was exerted through activating PPAR‐γ, we administered the PPAR‐γ antagonist GW9662 (4 mg/kg) along with RSG 1 hour before MCAO through intraperitoneal injection. The gene discussed is PPARG; the disease is stroke disorder.